NCT03746977

Brief Summary

The present study aimed to determine the effect of different interventions on lean body mass maintenance under weight loss conditions in overweight and obese premenopausal women. Three study groups were implemented: (1) Protein supplementation (only) group (2) Protein supplementation and walking intervention (3) Protein supplementation, walking and WB-EMS-application. All protocols were applied for 16 week of intervention. A energy deficit of 500 kcal/d was intended however while group (1) focus consistently on energy restriction (500 kcal/d), in group (2) and (3) a combined physical activity (i.e. walking with a volume representing 250 kcal/d) and energy restriction (250 kcal/d) protocol was applied. Total protein uptake including protein supplementation was calculated to average around 1.2 g/kg body mass per day in groups (1) and 1.5 g/kg body mass/d in group (2) and (3). WB-EMS was applied 1.5x 20 min/week (i.e. each Tuesday and every second Thursday). Primary study endpoint was LBM as determined by Dual Energy x-Ray Absorptiometry.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 25, 2018

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

November 13, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 20, 2018

Completed
10 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2018

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

March 18, 2019

Status Verified

March 1, 2019

Enrollment Period

10 months

First QC Date

November 13, 2018

Last Update Submit

March 15, 2019

Conditions

Keywords

exerciseelectromyostimulationproteinweight reduction

Outcome Measures

Primary Outcomes (1)

  • Lean body mass

    Fat and bone free total body mass in kg

    changes from baseline to 16 week follow-up

Secondary Outcomes (6)

  • Total Body Fat

    changes from baseline to 16 week follow-up

  • Total Body Fat Rate

    changes from baseline to 16 week follow-up

  • Appendicular Skeletal Muscle Mass

    changes from baseline to 16 week follow-up

  • Visceral Body Fat

    changes from baseline to 16 week follow-up

  • Trunk fat

    changes from baseline to 16 week follow-up

  • +1 more secondary outcomes

Study Arms (3)

energy restriction and protein supplementation

ACTIVE COMPARATOR

Energy restriction of 500 kcal/d and total Protein Uptake (including Supplementation) of 1.2 g/kg body mass/d

Dietary Supplement: Protein

Energy restriction, walking and protein

ACTIVE COMPARATOR

Energy restriction of 250 kcal/d, increased energy consumption by walking (250 kcal/d) and total protein uptake (including supplementation) of 1.5 g/kg body mass/d

Dietary Supplement: ProteinBehavioral: Walking

Energy restriction, walking, protein and WB-EMS

ACTIVE COMPARATOR

Energy restriction of 250 kcal/d, increased energy consumption by walking (250 kcal/d), total protein uptake (including supplementation) of 1.5 g/kg body mass/d and WB-EMS application 1,5x 20 min/week

Dietary Supplement: ProteinBehavioral: WalkingBehavioral: WB-EMS application

Interventions

ProteinDIETARY_SUPPLEMENT

Protein supplementation 1.2 or 1.5 g/kg body mass/d

Energy restriction, walking and proteinEnergy restriction, walking, protein and WB-EMSenergy restriction and protein supplementation
WalkingBEHAVIORAL

Walking with a volume corresponding to 250 kcal/d

Energy restriction, walking and proteinEnergy restriction, walking, protein and WB-EMS

WB-EMS application 1.5x 20 min/week

Energy restriction, walking, protein and WB-EMS

Eligibility Criteria

Age25 Years - 50 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • premenopausal women 25-50 years old
  • overweight/obesity (body fat rate equal or higher 30%)

You may not qualify if:

  • medication and diseases affecting muscle and fat metabolism
  • pregnant or parturition \< 6 months
  • any condition or medication that prevent proper physical activity or WB-EMS application
  • holidays equal or more than 1 week during the intervention period
  • other interventions with impact on the primary and core secondary outcome (i.e. body fat parameters) started during the last year.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute of Medical Physics University of Erlangen-Nurnberg

Erlangen, 91052, Germany

Location

MeSH Terms

Conditions

OverweightObesityObesity, AbdominalMotor ActivityWeight Loss

Interventions

ProteinsWalking

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBehaviorBody Weight Changes

Intervention Hierarchy (Ancestors)

Amino Acids, Peptides, and ProteinsLocomotionMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaExerciseMotor Activity

Study Officials

  • Simon von Stengel, PhD

    Institute of Medical Physics, FAU Erlangen-Nürnberg, Germany

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Outcome assessors were not aware of the status of the participants and were not allowed to ask correspondingly. Each of the participants were blinded according to the treatment and intervention. Participants of the three study groups were not in contact.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Randomized controlled parallel group design with 3 study arms
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor Dr. Wolfgang Kemmler, Principal Investigator

Study Record Dates

First Submitted

November 13, 2018

First Posted

November 20, 2018

Study Start

January 25, 2018

Primary Completion

November 30, 2018

Study Completion

December 1, 2018

Last Updated

March 18, 2019

Record last verified: 2019-03

Locations